Operating Lease, Right-of-Use Asset in USD of AbCellera Biologics Inc. from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AbCellera Biologics Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2022 to Q3 2025.
  • AbCellera Biologics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $138M, a 102% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AbCellera Biologics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $138M +$69.6M +102% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $137M +$66.8M +95.2% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $68.7M -$2.59M -3.63% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $66.6M -$6.49M -8.88% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $68.3M 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 $70.2M 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $71.3M 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $73.1M -$7.7M -9.52% 31 Dec 2023 10-K 27 Feb 2025
Q4 2022 $80.8M 31 Dec 2022 10-K 20 Feb 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.